ZOTEFOAMS PLC — Director's Dealing 2020

Apr 8, 2020

National Storage Mechanism | Additional information

RNS Number : 2663J

Zotefoams PLC

08 April 2020

Zotefoams plc

(the 'Company')

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

On 7 April 2020, the Company received notice from its Employee Benefit Trust of the exercise of awards granted under the Deferred Bonus Share Plan ("DBSP") by Mr D B Stirling and Mr G C McGrath as follows:

Director	Number of awards exercised	Price per share	Aggregate number of shares held
D B Stirling	10,575	1.59	503,555
G C McGrath	6,866	1.59	42,503

Awards granted under the DBSP vest three years from grant, subject to satisfaction of service conditions. The awards were increased to reflect the dividends paid during the restricted period in accordance with the rules of the Plan.

The Notification of Dealing Form for each Director can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

8 April 2020

About Zotefoams plc:      

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology.  Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets.  In addition, Zotefoams owns and licenses patented microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

AZOTE®, ZOTEK®, T-FIT®, ReZorce® are registered trademarks of Zotefoams plc

www.zotefoams.com

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Burns Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)	Volume(s)
£1.59	10,575

d)

Aggregated information:

Aggregate Price	Aggregate Volume	Aggregate Total
£1.59	10,575	£16,814.25

e)

Date of the transaction: 7 April 2020

f)

Place of the transaction: XLON

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary Christopher McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)	Volume(s)
£1.59	6,866

d)

Aggregated information:

Aggregate Price	Aggregate Volume	Aggregate Total
£1.59	6,866	£10,916.94

e)

Date of the transaction: 7 April 2020

f)

Place of the transaction: XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEASLPEFXEEFA